These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 5456175)

  • 1. The effects of haloperidol and chlorpromazine on amphetamine metabolism and amphetamine stereotype behavior in the rat.
    Lemberger L; Witt ED; Davis JM; Kopin IJ
    J Pharmacol Exp Ther; 1970 Sep; 174(3):428-33. PubMed ID: 5456175
    [No Abstract]   [Full Text] [Related]  

  • 2. Pharmacology and biochemistry of bromperidol.
    Niemegeers CJ; Laduron PM; Janssen PA
    Acta Psychiatr Belg; 1978; 78(1):37-50. PubMed ID: 645406
    [No Abstract]   [Full Text] [Related]  

  • 3. The action of neuroleptics in rats with altered catecholamine metabolism. IV. Behavioral and biochemical effects of chlorpromazine and haloperidol in rats pretreated with inhibitors of dopamine-beta-hydroxylase.
    Vetulani J
    Arch Immunol Ther Exp (Warsz); 1973; 21(3):501-6. PubMed ID: 4730817
    [No Abstract]   [Full Text] [Related]  

  • 4. The effect of certain drugs on amphetamine-induced stereotyped behavior and brain amphetamine levels in the rat.
    Lal S; Missala K; Sourkes TL; Feldmuller F
    Biol Psychiatry; 1974 Aug; 9(1):3-10. PubMed ID: 4156181
    [No Abstract]   [Full Text] [Related]  

  • 5. Effects of chlorpromazine and haloperidol on the disposition of mescaline-14C in mice.
    Shah NS; Shah KR; Lawrence RS; Neely AE
    J Pharmacol Exp Ther; 1973 Aug; 186(2):297-304. PubMed ID: 4719782
    [No Abstract]   [Full Text] [Related]  

  • 6. Iprindole-amphetamine interactions in the rat: the role of aromatic hydroxylation of amphetamine in its mode of action.
    Freeman JJ; Sulser F
    J Pharmacol Exp Ther; 1972 Nov; 183(2):307-15. PubMed ID: 4673401
    [No Abstract]   [Full Text] [Related]  

  • 7. The action of neuroleptics in rats with altered catecholamine metabolism. I. The influence of MAO inhibitors on the behavioral actions of chlorpromazine, haloperidol, and thioridazine.
    Vetulani J
    Pol J Pharmacol Pharm; 1973; 25(1):41-52. PubMed ID: 4798098
    [No Abstract]   [Full Text] [Related]  

  • 8. [Action of three neuroleptics on the DOPAC level in the caudate nucleus of the rat].
    Gerardy J; Cajgfinger G
    Arch Int Pharmacodyn Ther; 1972 Sep; 199(1):197-200. PubMed ID: 5072188
    [No Abstract]   [Full Text] [Related]  

  • 9. Effect of neuroleptics on brain amphetamine concentrations in the rat.
    Lal S; Missala K; Sourkes T
    J Pharm Pharmacol; 1971 Dec; 23(12):967-9. PubMed ID: 4402025
    [No Abstract]   [Full Text] [Related]  

  • 10. [Psychopharmacological analysis of the action of chlorpromazine, haloperidol and pentobarbital in simultaneous double conditioning].
    Molinengo L; Ricci-Galamero S
    Boll Soc Ital Biol Sper; 1971 Jul; 47(13):388-92. PubMed ID: 5133290
    [No Abstract]   [Full Text] [Related]  

  • 11. Effect of chlorpromazine on the disposition and excretion of amphetamine in the rat.
    Borella LE; Pinski J; Herr F
    Res Commun Chem Pathol Pharmacol; 1970 Sep; 1(5):667-76. PubMed ID: 5524269
    [No Abstract]   [Full Text] [Related]  

  • 12. Evidence for involvement of dopamine in the action of diazepam: potentiation of haloperidol and chlorpromazine action in the brain.
    Rastogi RB; Lapierre YD; Singhal RL; Nair NP
    Adv Biochem Psychopharmacol; 1980; 24():283-9. PubMed ID: 6996443
    [No Abstract]   [Full Text] [Related]  

  • 13. Pimozide, a chemically novel, highly potent and orally long-acting neuroleptic drug. I. The comparative pharmacology of pimozide, haloperidol, and chlorpromazine.
    Janssen PA; Niemegeers CJ; Schellekens KH; Dresse A; Lenaerts FM; Pinchard A; Schaper WK; van Nueten JM; Verbruggen FJ
    Arzneimittelforschung; 1968 Mar; 18(3):261-79. PubMed ID: 4386815
    [No Abstract]   [Full Text] [Related]  

  • 14. Is it possible to predict the clinical effects of neuroleptic drugs (major tranquillizers) from animal data? IV. An improved experimental design for measuring the inhibitory effects of neuroleptic drugs on amphetamine-or apomorphine-induced "Cheroing" and "agitation" in rats.
    Janssen PA; Niemegeers CJ; Schellekens KH; Lenaerts FM
    Arzneimittelforschung; 1967 Jul; 17(7):841-54. PubMed ID: 5632842
    [No Abstract]   [Full Text] [Related]  

  • 15. The effect of beta -phenylethylamine on behavior and polyribosomes in the rat.
    Widelitz MM
    Biochem Biophys Res Commun; 1979 Jan; 86(1):48-56. PubMed ID: 435304
    [No Abstract]   [Full Text] [Related]  

  • 16. Neurochemical changes associated with chronic administration of typical antipsychotics and its relationship with tardive dyskinesia.
    Bishnoi M; Chopra K; Kulkarni SK
    Methods Find Exp Clin Pharmacol; 2007 Apr; 29(3):211-6. PubMed ID: 17520104
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lack of major effects of ethanol, chlorpromazine, hexobarbital and haloperidol on brain gangliosides.
    Miller-Podraza H; Rakowska M; Skarzyńska E
    Acta Biochim Pol; 1990; 37(2):243-50. PubMed ID: 2072982
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effect of chlorpromazine and haloperidol on a conditioned behavior of temporal discrimination in the pigeon].
    Gatti GL
    Riv Sper Freniatr Med Leg Alien Ment; 1966 Jun; 90(3):652-7. PubMed ID: 5994564
    [No Abstract]   [Full Text] [Related]  

  • 19. Effect of amphetamine and chlorpromazine on maternal behaviour of rats.
    Franková S
    Act Nerv Super (Praha); 1972 Aug; 14(3):166-7. PubMed ID: 5066096
    [No Abstract]   [Full Text] [Related]  

  • 20. Distribution and metabolism of neuroleptic drugs. I. Pharmacokinetics of haloperidol.
    Lewi PJ; Heykants JJ; Allewijn FT; Dony JG; Janssen PA
    Arzneimittelforschung; 1970 Jul; 20(7):943-8. PubMed ID: 5536066
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.